Parexel Introduces New Dedicated Division to Help Emerging Biotech Companies Reach their Goals Quickly and Cost-Effectively



Press Releases


Blog Highlights

A New Day for Parexel

Today we are pleased to introduce Parexel’s new look.


Read More

The Parexel Podcast Episode 2: Tackling Rare Diseases & Inside the FDA

Amy, Mo and Zizi discuss how the industry can work to deliver more innovative treatments and the reality of working with the FDA.


Read More

Unlocking Drug Development Innovation with the Right People, Processes & Culture

Learn about Parexel's multi-layered approach to ensuring the strength and integrity of our global workforce, and more.


Read More

Ask The Expert Blog Series: Malaria

On World Malaria Day, Nathalie Sohier, MD, MPH, shares her personal perspective on the current state of malaria treatment.


Read More

In the News


March 25th, 2019

FierceBiotech: Alzprotect Pens PAREXEL Brain Disease Pact Using New Biotech Division

Read More


March 19th, 2019

Manufacturing Chemist: Rare Diseases: Understanding The Patient Journey

Read More


March 5th, 2019

Clinical Researcher: Engaged Patient Perspective Key To Expanding Clinical Trial Success

Read More




Media Resources & Contacts


Lori Preuit Dorer

Vice President, Executive & Strategic Communications

T: 978.495.4135

Wendy Ryan

Senior Director, Global Public Relations

T: 781.434.5104

We are always available for a conversation.